Birgit Wehnl
Penzberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: July 01, 2026
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 16, 2023
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 16, 2023
Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 07, 2023
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 23, 2020
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 18, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 24, 2018
Multicenter Evaluation of A New Progastrin-releasing Peptide (ProGRP) Immunoassay across Europe and China
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: September 01, 2017
Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis.
Journal: British journal of cancer
Published: January 19, 2017
Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 15, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026